Aims: The aim of this study was to determine the antimicrobial and antiadhesive properties of a biosurfactant isolated from Lactobacillus paracasei ssp. paracasei A20 against several micro-organisms, including Gram-positive and Gram-negative bacteria, yeasts and filamentous fungi. Methods and Results: Antimicrobial and antiadhesive activities were determined using the microdilution method in 96-well culture plates. The biosurfactant showed antimicrobial activity against all the micro-organisms assayed, and for twelve of the eighteen micro-organisms (including the pathogenic Candida albicans, Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis and Streptococcus agalactiae), the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) were achieved for biosurfactant concentrations between 25 and 50 mg ml )1 . Furthermore, the biosurfactant showed antiadhesive activity against most of the micro-organisms evaluated.
Introduction
Biosurfactants are amphiphilic compounds produced by micro-organisms with pronounced surface and emulsifying activities. These molecules exhibit a distinct tendency to accumulate at the interface between fluid phases that show different degrees of polarity and hydrogen bonding, such as oil and water or air and water, reducing the surface and interfacial tension (Van Hamme et al. 2006) . Different groups of biosurfactants exhibit diverse properties and display a variety of physiological functions in the producer micro-organisms; these include enhancing the solubility of hydrophobic ⁄ water-insoluble compounds, heavy metal binding, bacterial pathogenesis, cell adhesion and aggregation, quorum sensing and biofilm formation (Ron and Rosenberg 2001; Singh and Cameotra 2004) .
Several biosurfactants exhibit antibacterial, antifungal and antiviral activities, which make them relevant molecules for applications in combating many diseases and infections. Biosurfactants with known antimicrobial activity include surfactin and iturin produced by Bacillus subtilis strains (Ahimou et al. 2000) , mannosylerythritol lipids from Candida antarctica (Arutchelvi et al. 2008) , rhamnolipids from Pseudomonas aeruginosa (Benincasa et al. 2004 ) and biosurfactants isolated from Streptococcus thermophilus A and Lactococcus lactis 53 (Rodrigues et al. 2004 (Rodrigues et al. , 2006b .
Another valuable application of biosurfactants is their use as antiadhesive agents against pathogens. Adsorption of biosurfactants to a substratum surface modifies its hydrophobicity, interfering in the microbial adhesion and desorption processes (Rodrigues et al. 2006a) ; in that sense, the release of biosurfactants by probiotic bacteria in vivo can be considered as a defence weapon against other colonizing strains in the urogenital and gastrointestinal tracts (Van Hoogmoed et al. 2004) . Biosurfactants produced by lactobacilli have been shown to reduce adhesion of pathogenic micro-organisms to glass (Velraeds et al. 1996) , silicone rubber (Busscher et al. 1997) , surgical implants (Gan et al. 2002) and voice prostheses (Rodrigues et al. 2004 (Rodrigues et al. , 2006d . Consequently, previous adsorption of biosurfactants can be used as a preventive strategy to delay the onset of pathogenic biofilm growth on catheters and other medical insertional materials, reducing the use of synthetic drugs and chemicals (Rodrigues et al. 2006a; Singh et al. 2007; Falagas and Makris 2009) .
The aim of this study was to determine the antimicrobial and antiadhesive properties of a biosurfactant isolated from Lact. paracasei ssp. paracasei A20 against a group of pathogenic and nonpathogenic micro-organisms.
Materials and methods

Strains and culture conditions
A lactobacilli strain isolated from a Portuguese dairy plant, Lact. paracasei ssp. paracasei A20, was used for biosurfactant production. This strain was found to be a biosurfactant-producing strain in a previous work (data not shown).
The strain was stored at )80°C in MRS broth (Oxoid, Basingstoke, UK) containing 15% (v ⁄ v) glycerol solution until it was used. Whenever required, frozen stocks were streaked on MRS agar plates and incubated overnight at 37°C for further culturing. Working stock cultures were kept at 4°C for up to 2 weeks.
Several strains were used to test the antimicrobial and antiadhesive properties of the biosurfactant. Lactobacillus casei 36, Lact. casei 72, Lactobacillus reuteri 104R and Lact. reuteri ML1 were cultured in MRS broth; Streptococcus mutans NS, Strept. mutans HG985, Streptococcus oralis J22 and Streptococcus sanguis 12 were cultured in Todd-Hewitt Broth; Escherichia coli, Ps. aeruginosa, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus agalactiae and Streptococcus pyogenes were cultured in trypticase soy broth; Candida albicans was grown in yeast mould broth; the strains Malassezia sp., Trichophyton mentagrophytes and Trichophyton rubrum were cultured in Sabouraud dextrose broth (all media were obtained from Oxoid). All the strains were grown at 37°C, with the exception of C. albicans (31°C), T. mentagrophytes (26°C) and T. rubrum (26°C). Strains were stored at )80°C in the appropriate medium containing 15% (v ⁄ v) glycerol solution until they were used. Whenever required, frozen stocks were streaked on agar plates and incubated overnight at the optimum growing temperature for each strain for further culturing. Working stock cultures were kept at 4°C for up to 2 weeks.
Biosurfactant production and isolation
For crude biosurfactant production by Lact. paracasei ssp. paracasei A20 in flasks, 600 ml of culture broth were inoculated with 6 ml of an overnight subculture and incubated for 72 h at 37°C and 120 rev min )1 . The growth media used for the production of biosurfactant was MRS-Lac medium (standard medium where glucose was replaced by lactose). After 72 h, cells were harvested by centrifugation (10 000 g, 5 min, 10°C), washed twice in demineralized water and resuspended in 100 ml of phosphate-buffered saline (PBS: 0AE01 mol l )1 KH 2 PO 4 ⁄ K 2 HPO 4 and 0AE15 mol l )1 NaCl, adjusted to pH 7AE0). The suspension was kept at room temperature for 2 h with gentle stirring for biosurfactant release (Rodrigues et al. 2006b,c) . Subsequently, bacterial cells were removed by centrifugation, and the remaining supernatant liquid was filtered through a 0AE22-lm pore-size filter (Millipore, Bedford, MA, USA). The supernatant was dialysed against demineralized water at 4°C in a Cellu-Sep ª membrane (molecular weight cutoff 6000-8000 Dalton; Membrane Filtration Products, Seguin, TX, USA) and freeze-dried. Once dried, the biosurfactant was stored at )20°C for further studies. To confirm the biosurfactant production, the surface tension was routinely measured using the Ring method as previously described (Kim et al. 2000) .
Antimicrobial assays
The antimicrobial activity of the crude biosurfactant against several microbial strains was determined by the microdilution method in 96-well flat-bottom plastic tissue culture plates (Greiner Bio-One GmbH, Frickenhausen, Germany).
For each strain, appropriate medium and temperature were used (as previously described); briefly, 125 ll of sterile, double-strength culture medium were placed into the first column of the 96-well microplate and 125 ll of sterile, single-strength culture medium in the remaining wells. Subsequently, 125 ll of biosurfactant solution in PBS (100 mg ml )1 ) were added to the first column of the mi-croplate and mixed with the medium; this results in a biosurfactant concentration of 50 mg ml )1 ; serially, 125 ll were transferred to the subsequent wells, discarding 125 ll of the mixture in the tenth column, so that the final volume for each well was 125 ll. This process results in twofold serial dilutions of the biosurfactant in the first 10 columns (50-0AE09 mg ml )1 ). Columns 11 and 12 did not contain biosurfactant and served as negative and growth controls, respectively. All the wells (except for the 11th column) were inoculated with 2AE5 ll of an overnight culture at the defined optimum conditions, diluted to 10 8 CFU ml )1 . Microplates were covered and incubated for 48 h under the appropriate growth conditions for each micro-organism. Triplicate assays were performed at all the biosurfactant concentrations for each strain. After 48 h of incubation, the absorbance at 600 nm (A 600 ) was determined for each well. The growth inhibition percentages at different biosurfactant concentrations for each micro-organism were calculated as:
where A c represents the absorbance of the well with a biosurfactant concentration c and A 0 the absorbance of the control well (without biosurfactant).
The minimum inhibitory concentration (MIC) was determined for each strain as the lowest concentration of biosurfactant that completely inhibits measurable growth (A 600 = 0). To establish the minimum bactericidal concentration (MBC), 100 ll of each well with no visible growth were transferred into a tube with 5 ml of the appropriate medium and were incubated for 5 days under appropriate temperature. After that, the A 600 of each tube was determined. The lowest concentration of biosurfactant that did not allow growth was considered as the MBC for that strain. Tubes that showed growth were considered to come from wells with bacteriostatic concentration of biosurfactant.
Anti-adhesion assays
The antiadhesive activity of the crude biosurfactant isolated from Lact. paracasei ssp. paracasei A20 against several microbial strains was quantified according to the procedure described by Heinemann et al. (2000) . Briefly, the wells of a sterile 96-well flat-bottomed plastic tissue culture plate (Greiner Bio-One GmbH) were filled with 200 ll of the crude biosurfactant. Several biosurfactant concentrations were tested ranging from 3 to 50 mg ml )1 .
The plate was incubated for 18 h at 4°C and subsequently washed twice with PBS. Control wells contained PBS buffer only. An aliquot of 200 ll of a washed bacterial or yeast suspension (10 8 CFU ml )1 ) was added and incubated in the wells for 4 h at 4°C. Unattached micro-organisms were removed by washing the wells three times with PBS. The adherent micro-organisms were fixed with 200 ll of methanol (99% purity) per well, and after 15 min, the plates were emptied and left to dry. Then the plates were stained for 5 min with 200 ll of 2% crystal violet used for Gram staining per well. Excess stain was rinsed out by placing the plate under running tap water. Subsequently, the plates were air dried, the dye bound to the adherent micro-organisms was resolubilized with 200 ll of 33% (v ⁄ v) glacial acetic acid per well, and the absorbance of each well was measured at 595 nm. The microbial inhibition percentages at different biosurfactant concentrations for each micro-organism were calculated as:
where A c represents the absorbance of the well with a biosurfactant concentration c and A 0 the absorbance of the control well. The microtitre-plate antiadhesion assay estimates the percentage of microbial adhesion reduction in relation to the control wells, which were set at 0% to indicate the absence of biosurfactant and therefore of its anti-adhesion properties. In contrast, negative percentage results indicate the percentage increase in microbial adhesion at a given surfactant concentration in relation to the control. The microtitre-plate anti-adhesion assay allows the estimation of the crude biosurfactant concentrations that are effective in decreasing adhesion of the micro-organisms studied.
Results
Antimicrobial activity
The antimicrobial activity of the crude biosurfactant isolated from Lact. paracasei ssp. paracasei A20 was determined by measuring the growth inhibition percentages obtained for several micro-organisms (Table 1) . From those results, the MIC for each micro-organism was determined. Furthermore, whenever possible, the MBC was also determined. This biosurfactant was effective against all the microorganisms tested, albeit to different degrees. With regard to the nonpathogenic Lactobacillus strains and the Streptococcus species associated with the oral cavity (Strep. sanguis, Strep. mutans and Strep. oralis), in all the microorganisms a complete growth inhibition was observed for biosurfactant concentrations between 25 and 50 mg ml )1 , except for cariogenic Strep. mutans NS and Strep. mutans HG985. Regarding the pathogenic bacteria studied (E. coli, Ps. aeruginosa, Staph. aureus, Staph. epidermidis, Strep. pyogenes and Strep. agalactiae), with the exception of Ps. aeruginosa, a complete growth inhibition was also achieved for all the micro-organisms with biosurfactant concentrations between 25 and 50 mg ml )1 . Regarding the pathogenic yeasts, a total growth inhibition was observed for C. albicans with a biosurfactant concentration of 50 mg ml )1 , but not for Malassezia sp. under any of biosurfactant concentrations tested. The same occurred with the skin-associated pathogenic fungi (T. mentagrophytes and T. rubrum). For all the micro-organisms studied, the antimicrobial activity was observed even at low biosurfactant concentrations, and a complete growth inhibition was achieved for 12 of the 18 micro-organisms at the highest biosurfactant concentration assayed (50 mg ml )1 ). Furthermore, it is noticeable that even when MIC and MBC were not achieved, a high growth inhibition was observed (from 71AE6 to 91AE5%) with the highest biosurfactant concentration assayed (50 mg ml )1 ).
Antiadhesive activity
The antiadhesive activity of this biosurfactant was evaluated against a variety of bacterial and fungal strains. The biosurfactant showed antiadhesive activity against most of the micro-organisms tested, but the antiadhesive effect depends on the concentration and the micro-organism tested (Table 2) .
With regard to the nonpathogenic Lactobacillus strains, the antiadhesive activity was higher against Lact. reuteri strains (77AE6-78AE8% inhibition) than against Lact. casei strains (56AE5-63AE8% inhibition) for a biosurfactant concentration of 50 mg ml )1 . For streptococci associated with the oral cavity, the highest antiadhesive percentages were obtained for Strep. sanguis 12 (72AE9%), whereas the lowest were for Strep. mutans HG985 (31AE4%). Regarding the pathogenic bacteria, high antiadhesive percentages were obtained for Staph. aureus (76AE8%), Staph. epidermidis (72AE9%) and Strep. agalactiae (66AE6%); on the contrary, low activity was obtained for Ps. aeruginosa (21AE2%) and E. coli (11AE8%). In the same way, the antiadhesive activity against the yeasts and fungi strains studied was quite low even at the highest biosurfactant concentrations assayed (between 15AE3 and 38AE9% inhibition).
Discussion
The crude biosurfactant isolated from Lact. paracasei ssp. paracasei A20 showed antimicrobial activity against a broad range of micro-organisms, including Gram-positive and Gram-negative bacteria, as well as yeasts and filamentous fungi. For 12 of the 18 micro-organisms studied, the MIC and the MBC were determined for the biosurfactant range of concentrations between 25 and 50 mg ml )1 . As far as we know, this is the first compilation of data on antimicrobial activity of biosurfactants obtained from lactobacilli against such a broad group of micro-organisms. Candida albicans 56AE3 ± 0AE7 6 5 AE3 ± 0AE6 7 7 AE3 ± 0AE7 8 9 AE9 ± 0AE7 100AE0 ± 0AE0* Escherichia coli 59AE0 ± 0AE5 7 2 AE8 ± 0AE6 8 9 AE6 ± 0AE8 100AE0 ± 0AE0 100AE0 ± 0AE0* Lactobacillus casei 36 53AE5 ± 0AE6 6 9 AE8 ± 1AE3 8 5 AE3 ± 0AE5 100AE0 ± 0AE0* 100AE0 ± 0AE0 Lact. casei 72 61AE7 ± 0AE8 7 4 AE3 ± 0AE9 8 4 AE3 ± 0AE4 100AE0 ± 0AE0* 100AE0 ± 0AE0 Lactobacillus reuteri 104R 60AE8 ± 0AE7 7 5 AE5 ± 0AE7 8 3 AE7 ± 0AE5 9 6 AE0 ± 0AE5 100AE0 ± 0AE0* Lact. reuteri ML1 62AE8 ± 0AE7 7 6 AE8 ± 0AE4 8 4 AE5 ± 0AE4 9 4 AE5 ± 0AE6 100AE0 ± 0AE0* Malassezia sp.
40AE0 ± 0AE3 4 9 AE5 ± 0AE6 5 4 AE3 ± 0AE7 6 2 AE5 ± 0AE4 7 1 AE6 ± 1AE5 Pseudomonas aeruginosa 50AE9 ± 0AE8 5 8 AE8 ± 0AE6 6 9 AE3 ± 0AE6 8 3 AE5 ± 1AE1 9 1 AE5 ± 0AE5 Staphylococcus aureus 63AE1 ± 0AE4 7 5 AE9 ± 1AE0 8 6 AE4 ± 0AE6 9 5 AE2 ± 0AE5 100AE0 ± 0AE0* Staphylococcus epidermidis 71AE4 ± 0AE7 8 5 AE9 ± 0AE9 9 1 AE0 ± 0AE7 9 6 AE7 ± 0AE6 100AE0 ± 0AE0* Streptococcus agalactiae 51AE5 ± 0AE8 6 4 AE3 ± 0AE6 7 6 AE8 ± 0AE8 100AE0 ± 0AE0 100AE0 ± 0AE0* Streptococcus mutans HG 985 48AE5 ± 0AE9 5 7 AE7 ± 0AE7 6 7 AE5 ± 0AE6 7 4 AE8 ± 1AE3 8 8 AE3 ± 0AE9 Strep. mutans NS 40AE0 ± 1AE0 5 1 AE8 ± 0AE6 6 4 AE1 ± 2AE2 7 4 AE1 ± 0AE7 8 3 AE9 ± 0AE8 Streptococcus oralis J22 44AE3 ± 0AE6 5 6 AE9 ± 1AE0 7 3 AE6 ± 1AE0 100AE0 ± 0AE0 100AE0 ± 0AE0* Streptococcus pyogenes 57AE8 ± 0AE4 6 8 AE8 ± 0AE5 8 1 AE6 ± 0AE4 100AE0 ± 0AE0 100AE0 ± 0AE0* Streptococcus sanguis 12 52AE0 ± 0AE6 6 1 AE7 ± 0AE6 7 5 AE9 ± 0AE6 8 8 AE6 ± 0AE7 100AE0 ± 0AE0* Trichophyton mentagrophytes 41AE3 ± 0AE6 5 1 AE9 ± 0AE5 6 2 AE7 ± 0AE7 7 0 AE3 ± 1AE1 7 8 AE6 ± 0AE9 Trichophyton rubrum 47AE2 ± 0AE4 5 6 AE6 ± 0AE5 6 5 AE3 ± 0AE5 7 6 AE8 ± 0AE7 8 6 AE1 ± 0AE7 *Indicates the minimum bactericidal concentration (MBC).
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Several biosurfactants that exhibit antimicrobial activity have been previously described. However, there are few reports about the antimicrobial activity of biosurfactants isolated from lactobacilli; only biosurfactants obtained from Strep. thermophilus A and L. lactis 53 showed significant antimicrobial activity against several bacterial and yeast strains isolated from explanted voice prostheses (Rodrigues et al. 2004 (Rodrigues et al. , 2006b . In that sense, the antimicrobial activity of the crude biosurfactant isolated from Lact. paracasei ssp. paracasei A20 against C. albicans, Staph. aureus and Staph. epidermidis was similar to that obtained with the crude biosurfactants isolated from L. lactis 53 and Strep. thermophilus A, which completely inhibited the growth of those micro-organisms with concentrations between 25 and 100 mg ml )1 (Rodrigues et al. 2004) . In addition to the antimicrobial properties, the biosurfactant isolated in this study exhibited a considerable antiadhesive activity against most of the micro-organisms tested. Involvement of biosurfactants in microbial adhesion and desorption has been widely described, and adsorption of biosurfactants isolated from lactobacilli to solid surfaces might constitute an effective strategy to reduce microbial adhesion and combating colonization by pathogenic micro-organisms, not only in the biomedical field, but also in other areas, such as the food industry (Rodrigues et al. 2006a; Nitschke and Costa 2007; Singh et al. 2007; Falagas and Makris 2009 ).
The antiadhesive activity observed with this biosurfactant against several pathogenic micro-organisms such as Staph. aureus, Staph. epidermidis and Strep. agalactiae are very promising for further studies and applications aiming to reduce microbial colonization on different materials. However, this biosurfactant showed low antiadhesive activity against E. coli, C. albicans and Ps. aeruginosa, in contrast with the antimicrobial activity exhibited against these strains at the same biosurfactant concentrations.
The use and potential commercial applications of biosurfactants in the medical field has increased considerably in the last years. Their antimicrobial and antiadhesive properties make them relevant molecules for use in combating many diseases and infections and as therapeutic agents (Rodrigues et al. 2006a ). Falagas and Makris (2009) have proposed the application of biosurfactants isolated from probiotic bacteria to patient care equipments (such as catheters and other medical insertional devices) in hospitals, with the aim of decreasing colonization by microorganisms responsible for nosocomial infections.
In conclusion, in this work we have demonstrated the antimicrobial and antiadhesive properties of the crude biosurfactant isolated from Lact. paracasei ssp. paracasei A20 against several pathogenic and nonpathogenic microorganisms, including bacteria, yeasts and filamentous fungi. The results obtained suggest the possible use of this biosurfactant as an alternative antimicrobial agent in the medical field for applications against micro-organisms Candida albicans )23AE7 ± 2AE2 )15AE0 ± 1AE6 3 AE7 ± 0AE6 1 4 AE9 ± 1AE4 2 9 AE5 ± 1AE6 Escherichia coli )71AE4 ± 1AE4 )55AE2 ± 1AE8 )9AE8 ± 2AE3 3 AE1 ± 1AE7 1 1 AE8 ± 1AE6 Lactobacillus casei 36 31AE6 ± 2AE3 4 4 AE8 ± 0AE7 5 3 AE3 ± 1AE3 5 9 AE1 ± 0AE5 6 3 AE8 ± 1AE5 Lact. casei 72 11AE9 ± 0AE5 2 4 AE1 ± 1AE1 4 0 AE2 ± 0AE4 5 0 AE8 ± 1AE8 5 6 AE5 ± 0AE5 Lactobacillus reuteri 104R 16AE5 ± 1AE2 5 6 AE7 ± 0AE7 6 4 AE0 ± 1AE2 7 1 AE4 ± 1AE2 7 7 AE6 ± 1AE4 Lact. reuteri ML1 21AE6 ± 1AE0 5 3 AE6 ± 2AE1 6 5 AE3 ± 1AE0 6 8 AE9 ± 1AE0 7 8 AE8 ± 1AE5 Malassezia sp.
)17AE3 ± 0AE9 6 AE6 ± 0AE7 2 1 AE9 ± 2AE2 2 8 AE9 ± 1AE1 3 8 AE9 ± 2AE6 Pseudomonas aeruginosa )3AE1 ± 1AE3 9 AE6 ± 1AE1 1 4 AE5 ± 1AE3 1 6 AE5 ± 0AE8 2 1 AE2 ± 0AE9 Staphylococcus aureus 10AE3 ± 1AE2 5 1 AE1 ± 1AE4 6 2 AE0 ± 1AE1 7 2 AE0 ± 1AE6 7 6 AE8 ± 1AE4 Staphylococcus epidermidis 2AE1 ± 1AE0 4 1 AE6 ± 1AE0 5 4 AE4 ± 1AE3 6 2 AE1 ± 1AE5 7 2 AE9 ± 0AE3 Streptococcus agalactiae 18AE3 ± 1AE1 3 7 AE6 ± 0AE7 4 8 AE8 ± 2AE3 6 0 AE0 ± 0AE8 6 6 AE6 ± 1AE2 Streptococcus mutans HG 985 3AE1 ± 1AE3 1 3 AE2 ± 1AE3 1 6 AE1 ± 1AE3 2 3 AE7 ± 2AE1 3 1 AE4 ± 0AE6 Strep. mutans NS 4AE5 ± 1AE2 1 3 AE4 ± 1AE5 1 9 AE7 ± 1AE6 2 7 AE5 ± 0AE4 3 8 AE6 ± 0AE8 Streptococcus oralis J22 20AE7 ± 1AE5 3 1 AE0 ± 1AE5 3 4 AE9 ± 1AE7 4 5 AE2 ± 1AE1 5 5 AE5 ± 1AE9 Streptococcus pyogenes 2AE1 ± 1AE4 1 2 AE9 ± 0AE5 3 2 AE2 ± 1AE0 3 8 AE0 ± 0AE1 4 0 AE9 ± 1AE2 Streptococcus sanguis 12 14AE5 ± 0AE9 3 3 AE4 ± 1AE2 5 4 AE5 ± 0AE5 6 2 AE4 ± 1AE7 7 2 AE9 ± 0AE6 Trichophyton mentagrophytes )26AE4 ± 1AE1 )18AE5 ± 1AE5 )3AE3 ± 1AE9 9 AE4 ± 1AE3 2 5 AE7 ± 1AE2 Trichophyton rubrum )25AE1 ± 1AE9 )17AE5 ± 1AE0 )6AE4 ± 0AE9 3 AE9 ± 1AE5 1 5 AE3 ± 1AE1
responsible for diseases and infections in the urinary, vaginal and gastrointestinal tracts, as well as in the skin, making it a suitable alternative to conventional antibiotics.
